What's Hot

View all perspectives
      RT @Yuz6Yusof: #ACR21 Year In Review: Factors associated with #COVID deaths in pts with #RMD:
      ⛔️age, male, HTN/CVD,

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      #ACR21 Year In Review: Factors associated with #COVID deaths in pts with #RMD: ⛔️age, male, HTN/CVD, lung disease, steroid>10mg/d, ⬆️disease activity ⛔️RTX (OR: 4), SFZ (3.6), other IS (2.2), No DMARDs (2.1) vs MTX monotherapy as reference @RheumNow https://t.co/Zd6qXCtGLk https://t.co/YHBEelLqKB
      RT @Yuz6Yusof: #Abstr0076 #ACR21 Can we predict #thrombosis in #lupus patients? Predictors of serology transition at 5yr

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      #Abstr0076 #ACR21 Can we predict #thrombosis in #lupus patients? Predictors of serology transition at 5yrs: ✅LAC+ to LAC-:Afro-American,HCQ and normal C3 ⛔️LAC+ to 🩸Clot:Obesity, low C3 and not on HCQ Data need in those with Triple Positivity @RheumNow https://t.co/byeL5NjVUS https://t.co/CchtZir2GN
      RT @Yuz6Yusof: #Abstr0002 #ACR21 What drives salt in saliva in #sjogren? A study suggested Bcell cytokines mediated the

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      #Abstr0002 #ACR21 What drives salt in saliva in #sjogren? A study suggested Bcell cytokines mediated the epithelial Na+ Channel disruption. A case for targeting Bcell to improve oral health @RheumNow https://t.co/Bx3kBpOIFX https://t.co/YYnC6UoMJY
      RT @Yuz6Yusof: Either we need to review the Yearly PAP cervical screening in SLE women or work hard to improve patient a

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      Either we need to review the Yearly PAP cervical screening in SLE women or work hard to improve patient awareness. Suspect the latter as time between tests was over 4 years late 😱 and 2.7% developed cancer #ACR21 #Abstr0133 @RheumNow https://t.co/wm01MfoFjf https://t.co/blD8WafZsE
      RT @Yuz6Yusof: #ACR21 #Abstr0454 Mortality rate in #lupus nephritis ⬇️by 26% from 1999-2019👏. BUT, racial and res

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      #ACR21 #Abstr0454 Mortality rate in #lupus nephritis ⬇️by 26% from 1999-2019👏. BUT, racial and residence disparities were concerning; worse in Black, Hispanic, Asian, AI/AN vs White and in large central and medium metro. Residential matters! @RheumNow https://t.co/33vN39acuL https://t.co/XMwN2hXJn7
      RT @Yuz6Yusof: #ACR21 #Abstr0768 We need to improve disparity among all levels of income. Support to the lowest income g

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 2 months ago
      #ACR21 #Abstr0768 We need to improve disparity among all levels of income. Support to the lowest income group seemed to improve but children with #lupus who were in the 2nd level income quartile had the longest length of stay in the hospital #RheumNow https://t.co/7HSveerUhs https://t.co/cSQBELopH5
      RT @swethaann23: A very strong and inspirational opening session quote "Create new better normal where you can create sy

      swethaann23 swethaann23

      3 years 2 months ago
      A very strong and inspirational opening session quote "Create new better normal where you can create systems that are resilient to a crisis and the foundation trend towards paradigm shift after what the pandemic has brought to light the gaps" #ACR21 #RheumNow @DoctorYasmin https://t.co/Ikbt9LiPwu
      RT @ericdeinmd: @DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to trea

      Eric Dein ericdeinmd

      3 years 2 months ago
      @DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
      RT @swethaann23: Looking forward to “What the fact” – how to differentiate from misinformation versus actual infor

      swethaann23 swethaann23

      3 years 2 months ago
      Looking forward to “What the fact” – how to differentiate from misinformation versus actual information in social media @DoctorYasmin @DrDavidKarp #ACR21 @RheumNow https://t.co/Wqh29NWNmq
      RT @swethaann23: A quick recap slide on VEXAS syndrome presentation. #ACR21 @RheumNow @petercgrayson https://t.co/4x8hB

      swethaann23 swethaann23

      3 years 2 months ago
      A quick recap slide on VEXAS syndrome presentation. #ACR21 @RheumNow @petercgrayson https://t.co/4x8hBEFWg2
      RT @swethaann23: Avacopan (C5a inhibitor) is a new promising therapy for ANCA vasculitis. US FDA approved in Oct 2021
      #A

      swethaann23 swethaann23

      3 years 2 months ago
      Avacopan (C5a inhibitor) is a new promising therapy for ANCA vasculitis. US FDA approved in Oct 2021 #ACR21 @rheumnow https://t.co/tWvKzHOT5V
      RT @swethaann23: Findings:
      1. 21% of the patients in the Ankylosing Spondylitis Registry of Ireland (ASRI) were unemploy

      swethaann23 swethaann23

      3 years 2 months ago
      Findings: 1. 21% of the patients in the Ankylosing Spondylitis Registry of Ireland (ASRI) were unemployed which is higher than their national average. 2. Stong predictors of unemployment were - Male sex and worse disease activity outcome measures(BASMI and ASQoL) #ACR21 @RheumNow
      RT @swethaann23: #ACR21 @RheumNow
      Abst#0359 by Garrido-Cumbrera et al. has mapped out the journey from symptom onset to

      swethaann23 swethaann23

      3 years 2 months ago
      #ACR21 @RheumNow Abst#0359 by Garrido-Cumbrera et al. has mapped out the journey from symptom onset to diagnosis of axSpA across 13 European countries.
      RT @swethaann23: #ACR21 @RheumNow
      Abst#0364 by Wetterslev et al. sought to identify axSpA characteristics of patients t

      swethaann23 swethaann23

      3 years 2 months ago
      #ACR21 @RheumNow Abst#0364 by Wetterslev et al. sought to identify axSpA characteristics of patients tapered off TNFI and showed clinical and radiographic improvement. 🔽52% were tapered off ⭐️The highest predictor of success is a low physician global VAS score
      RT @DrMiniDey: Our recap of Day 2 of #ACR21 is now available on YouTube and the @RheumNow website, where you can find lo

      Mrinalini Dey DrMiniDey

      3 years 2 months ago
      Our recap of Day 2 of #ACR21 is now available on YouTube and the @RheumNow website, where you can find lots more videos, interviews and articles from the conference! https://t.co/BxBXipxzif @drdavidliew @doctorRBC @swethaann23 @MeralElRamahiMD

      Podcasts

      • VITAL Info On Autoimmune Disease (2.9.2024)
      • Bah Humbug Vitamin D (12.20.2024)
      • 54K Peptic Ulcers Annually (12.13.2024)

      Catch up on Conference Podcasts

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright 2024 All Rights Reserved.

      ×